Skip to content

Evaluation of a Telephone Follow-up Procedure on the Quality of Life in Psychogenic Non-epileptic Seizures

Evaluation d'un Dispositif de Suivi téléphonique Sur la Qualité de Vie Dans Les Crises Psychogènes Non Epileptiques.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02311829
Acronym
EDUQ-CPNE
Enrollment
136
Registered
2014-12-08
Start date
2014-01-31
Completion date
2018-01-31
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychogenic Non Epileptic Seizure

Keywords

Quality of life, PNES, Epilepsy,

Brief summary

The goal of this study is to evaluate effectiveness of the phone follow-up method compared to the conventional filler taken one.

Detailed description

This study is a multicenter, non-drug therapy and randomized research trial, comparing a group of patients integrating the phone monitoring device (DST group) to a control group where patients are cared for in the usual way. Subject recruiting modalities: The study population represents patients diagnosis, PNES confirmed by following by the video-EEG, recorded in a center of epilepsy and in different CHU and informed of the diagnosis of PNES in a standardized manner. Patients were recruited during their hospitalization video-EEG is conducted in part of the diagnostic workup of drug-resistant epilepsies, or demonstrations paroxysmal undetermined which may prove to be PNES. Usual care: After diagnosis of PNES: orientation psychiatric care or CMP liberal and meeting biannual with the neurologist. In the study: * For patients in both groups: Management usual care and, in addition, quotation questionnaires of quality of life and evaluation by a neuropsychologist biannually for 24 months after the appointment with the neurologist. * For patients in the DST group only: Phone calls by psychologist at J 15, at 2 months, then every 2 months until M12. The device telephone follow (DST) consists of telephone calls (D15, M2, then every 2 months until M12) of the patient by an external independent psychologist designed to inform the patient about its pathology, promote acceptance of diagnosis, support the patient in his approach to care encouraging psychiatric observation. The device does not replace psychiatric counseling recommended.

Interventions

OTHERTelephone follow-up device

For patients in the DST group only: Phone calls by clinical psychologist at J 15 at 2, then every 2 months until M12.

Sponsors

Dr Coraline HINGRAY
CollaboratorUNKNOWN
Pr Raymund SCHWAN
CollaboratorUNKNOWN
Dr Vincent LAPREVOTE
CollaboratorUNKNOWN
Dr Jean Pierre VIGNAL
CollaboratorUNKNOWN
Pr Hervé VESPIGNANI
CollaboratorUNKNOWN
Dr Anne THIRIAUX
CollaboratorUNKNOWN
Dr Delphine RAUCHER CHENE
CollaboratorUNKNOWN
Dr Martine LEMESLE
CollaboratorUNKNOWN
Dr Benoît TROJAK
CollaboratorUNKNOWN
Pr Edouard HIRSCH
CollaboratorUNKNOWN
Pr Pierre Vidailhet
CollaboratorUNKNOWN
Dr Dominique Mastelli
CollaboratorUNKNOWN
Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient above 18 years old * Affiliation to social security * Evolution disorders for over three months with at least 3 psychogenic non-epileptic seizures spaced over 24 hours and less than two years * Diagnosis of PNES (associated or not with epilepsy) or laid confirmed following a video-EEG examination * Standardized announcement of the disease made by a neurologist participant / PHRC training * Good understanding of the French language * Patient consented to participate in the study

Exclusion criteria

* Acute psychiatric pathology at the time of inclusion warranting urgent hospitalization (acute suicidal risk, Table delusional ...) * Progressive neurological pathology intercurrent susceptible to aggravation for the duration of the study (glioma, multiple sclerosis, dementia ...) * A patient who can not physically comply with the six-monthly review at the discretion of the investigator (planned move ...) * Simultaneous participation to another therapeutic intervention study during the first 12 months

Design outcomes

Primary

MeasureTime frameDescription
Evolution of quality of life scores every 6 months (From 6 to 24 months)24 monthsThe primary endpoint is the assessment of quality of life scores measured at 6, 12, 18 and 24 months after start of treatment (visit D0) by self-administered questionnaires of quality of life (SF-36 general questionnaire quality of life) and QOLIE 31 (specific questionnaire epilepsy).

Secondary

MeasureTime frameDescription
Frequency of non epileptic seizures per month24 months (average for 6 months)Seizures diaries follow
Severity of seizures24 monthsDuration, injuries, loss of urine and feces, fall, loss of consciousness and subjective control feel of the listed crisis between 0 and 10 on EVA scale crisis control feel.
Psychiatric symptomology scores24 monthsQuestionnaires (DSM-IV, Beck 21, MADRS, HAMA, DES, SDQ-20, TAS 20, Brief COPE)
Percentage of programmed psychological consultation and actually honored in medical and psychological center24 monthsThis percentage is collected in medical and psychological center or from liberal psychiatrist \\ psychologist (collected with phone call)
Number of urgent consultations or unprogrammed and \ or unprogrammed24 monthsconsultations ( SAMU, emergency, reanimation, unprogrammed neurological consultations).

Countries

France

Contacts

Primary ContactLouis MAILLARD, PU-PH, HDR
l.maillard@chu-nancy.fr03 83 85 16 86
Backup ContactCoraline HINGRAY, PU-PH
c.hingray@chu-nancy.fr03 83 85 16 86

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026